NLS Pharmaceutics Stock Forecast - Maximum Drawdown

NLSP Stock  USD 0.13  0.01  7.14%   
NLS Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast NLS Pharmaceutics stock prices and determine the direction of NLS Pharmaceutics AG's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of NLS Pharmaceutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although NLS Pharmaceutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of NLS Pharmaceutics' systematic risk associated with finding meaningful patterns of NLS Pharmaceutics fundamentals over time.
Check out Historical Fundamental Analysis of NLS Pharmaceutics to cross-verify your projections.
  
As of 04/19/2024, Payables Turnover is likely to grow to 0.01, while Inventory Turnover is likely to drop (0.33). . As of 04/19/2024, Common Stock Shares Outstanding is likely to drop to about 13.6 M. In addition to that, Net Loss is likely to grow to about (10.2 M).
NLS Pharmaceutics AG has current Maximum Drawdown of 0.
Most investors in NLS Pharmaceutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the NLS Pharmaceutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets NLS Pharmaceutics' price structures and extracts relationships that further increase the generated results' accuracy.
Check NLS Pharmaceutics VolatilityBacktest NLS PharmaceuticsInformation Ratio  

NLS Pharmaceutics Trading Date Momentum

On April 19 2024 NLS Pharmaceutics AG was traded for  0.13  at the closing time. The top price for the day was 0.15  and the lowest listed price was  0.13 . There was no trading activity during the period 0.0. Lack of trading volume on April 19, 2024 did not cause price change. The trading delta at closing time against the current closing price is 15.38% .
Compare NLS Pharmaceutics to competition

Other Forecasting Options for NLS Pharmaceutics

For every potential investor in NLS, whether a beginner or expert, NLS Pharmaceutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. NLS Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in NLS. Basic forecasting techniques help filter out the noise by identifying NLS Pharmaceutics' price trends.

View NLS Pharmaceutics Related Equities

 Risk & Return  Correlation

NLS Pharmaceutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of NLS Pharmaceutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of NLS Pharmaceutics' current price.

NLS Pharmaceutics Market Strength Events

Market strength indicators help investors to evaluate how NLS Pharmaceutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NLS Pharmaceutics shares will generate the highest return on investment. By undertsting and applying NLS Pharmaceutics stock market strength indicators, traders can identify NLS Pharmaceutics AG entry and exit signals to maximize returns.

NLS Pharmaceutics Risk Indicators

The analysis of NLS Pharmaceutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in NLS Pharmaceutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting nls stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NLS Pharmaceutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NLS Pharmaceutics' short interest history, or implied volatility extrapolated from NLS Pharmaceutics options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether NLS Pharmaceutics is a strong investment it is important to analyze NLS Pharmaceutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NLS Pharmaceutics' future performance. For an informed investment choice regarding NLS Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of NLS Pharmaceutics to cross-verify your projections.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for NLS Stock analysis

When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is NLS Pharmaceutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NLS Pharmaceutics. If investors know NLS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NLS Pharmaceutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.50)
Return On Assets
(4.14)
Return On Equity
(8.63)
The market value of NLS Pharmaceutics is measured differently than its book value, which is the value of NLS that is recorded on the company's balance sheet. Investors also form their own opinion of NLS Pharmaceutics' value that differs from its market value or its book value, called intrinsic value, which is NLS Pharmaceutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NLS Pharmaceutics' market value can be influenced by many factors that don't directly affect NLS Pharmaceutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NLS Pharmaceutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if NLS Pharmaceutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NLS Pharmaceutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.